Merit Medical Systems (MMSI) EPS (Weighted Average and Diluted) (2010 - 2026)

Merit Medical Systems has disclosed EPS (Weighted Average and Diluted) across 17 years of filings, most recently posting $0.68 for Q1 2026.

• EPS (Weighted Average and Diluted) for Q1 2026 came in at $0.68, up 38.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.32 (up 13.73% YoY), and the FY2025 annual result was $2.13, up 4.93% from the prior year.
• EPS (Weighted Average and Diluted) came in at $0.68 for Q1 2026 at Merit Medical Systems, up from $0.64 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.68 in Q1 2026 to a low of $0.18 in Q1 2022.
• The 5-year median for EPS (Weighted Average and Diluted) is $0.48 (2024), against an average of $0.46.
• Across the five-year window, EPS (Weighted Average and Diluted) soared 200.0% in 2022 and declined 17.24% in 2023, its largest moves.
• Merit Medical Systems' EPS (Weighted Average and Diluted) stood at $0.58 in 2022, then slipped by 17.24% to $0.48 in 2023, then declined by 4.17% to $0.46 in 2024, then surged by 39.13% to $0.64 in 2025, then increased by 6.25% to $0.68 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at $0.68 (Q1 2026), $0.64 (Q4 2025), and $0.46 (Q3 2025), per Business Quant data.